Literature DB >> 22331395

Endovascular therapy for thoracic aortic aneurysms: state of the art in 2012.

Nicolas A Brozzi1, Eric E Roselli.   

Abstract

OPINION STATEMENT: Conventional surgery for thoracic aortic pathology involves replacing the affected segment of aorta with an interposition graft and often requires the use of extracorporeal circulatory support with or without deep hypothermic circulatory arrest. Although operative results have improved consistently over 60 years, patients with extensive aneurysms face a considerable risk with conventional surgery, particularly when burdened with multiple comorbidities. Thoracic endovascular aortic repair (TEVAR) was first performed in 1994 and has become a well-established alternative therapy for many thoracic aortic pathologies. TEVAR is most frequently performed through a small groin incision to access the common femoral artery. Wires and catheters are used to deliver and deploy the stent graft in the thoracic aorta under fluoroscopic control. Occasionally, TEVAR is performed as part of a complex hybrid procedure including one stage of conventional open surgery that may utilize a thoracic incision and cardiopulmonary bypass support. The less invasive nature of TEVAR offers the potential for lower mortality and peri-procedural morbidity. Although long-term results of TEVAR are still being gathered, mid-term results are excellent and most late vascular complications can be treated with additional transcatheter procedures. Recent development of fenestrated and branched stent grafts is expanding the application of endovascular therapies to complex aortic pathologies involving the thoracoabdominal aorta and aortic arch. Although conventional techniques continue to be the gold standard for treatment of ascending aortic pathology, recent reports have proven TEVAR to be a viable alternative in specific situations. Design improvements continue to expand the indications for TEVAR, and technological advancements in the field of imaging facilitate safer and more accurate planning, delivery, and assessment of patients with thoracic aortic aneurysms. Hybrid operating rooms provide the optimal environment with state of the art imaging technology for the cardiovascular team to perform TEVAR or alternative hybrid procedures.

Entities:  

Year:  2012        PMID: 22331395     DOI: 10.1007/s11936-012-0169-6

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  67 in total

1.  Regression of aortic aneurysms through pharmacologic therapy?

Authors:  Subodh Verma; Thomas F Lindsay
Journal:  N Engl J Med       Date:  2006-05-11       Impact factor: 91.245

2.  Early and late outcomes of acute type A aortic dissection: analysis of risk factors in 487 consecutive patients.

Authors:  Bruno Chiappini; Marc Schepens; Erwin Tan; Andrea Dell' Amore; Wim Morshuis; Karl Dossche; Marcello Bergonzini; Nicola Camurri; Letizia Bacchi Reggiani; Giuseppe Marinelli; Roberto Di Bartolomeo
Journal:  Eur Heart J       Date:  2004-12-07       Impact factor: 29.983

3.  Thoracoabdominal aneurysm repair: hybrid versus open repair.

Authors:  Rajendra Patel; Mark F Conrad; Vikram Paruchuri; Christopher J Kwolek; Thomas K Chung; Richard P Cambria
Journal:  J Vasc Surg       Date:  2009-07       Impact factor: 4.268

4.  Left subclavian artery coverage during thoracic endovascular aortic repair and risk of perioperative stroke or death.

Authors:  Jayer Chung; Karthikeshwar Kasirajan; Ravi K Veeraswamy; Thomas F Dodson; Atef A Salam; Elliot L Chaikof; Matthew A Corriere
Journal:  J Vasc Surg       Date:  2011-06-12       Impact factor: 4.268

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.

Authors:  Benjamin S Brooke; Jennifer P Habashi; Daniel P Judge; Nishant Patel; Bart Loeys; Harry C Dietz
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

Review 7.  The effect of left subclavian artery coverage on morbidity and mortality in patients undergoing endovascular thoracic aortic interventions: a systematic review and meta-analysis.

Authors:  Adnan Z Rizvi; M Hassan Murad; Ronald M Fairman; Patricia J Erwin; Victor M Montori
Journal:  J Vasc Surg       Date:  2009-11       Impact factor: 4.268

8.  Thoracic aortic aneurysms: a population-based study.

Authors:  L K Bickerstaff; P C Pairolero; L H Hollier; L J Melton; H J Van Peenen; K J Cherry; J W Joyce; J T Lie
Journal:  Surgery       Date:  1982-12       Impact factor: 3.982

9.  Great vessel management for endovascular exclusion of aortic arch aneurysms and dissections.

Authors:  P Bergeron; N Mangialardi; P Costa; P Coulon; V Douillez; E Serreo; I Tuccimei; C Cavazzini; F Mariotti; Y Sun; J Gay
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-03-07       Impact factor: 7.069

10.  Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts.

Authors:  Lars G Svensson; Nicholas T Kouchoukos; D Craig Miller; Joseph E Bavaria; Joseph S Coselli; Michael A Curi; Holger Eggebrecht; John A Elefteriades; Raimund Erbel; Thomas G Gleason; Bruce W Lytle; R Scott Mitchell; Christoph A Nienaber; Eric E Roselli; Hazim J Safi; Richard J Shemin; Gregorio A Sicard; Thoralf M Sundt; Wilson Y Szeto; Grayson H Wheatley
Journal:  Ann Thorac Surg       Date:  2008-01       Impact factor: 4.330

View more
  1 in total

Review 1.  Endovascular aortic aneurysm repair (EVAR).

Authors:  Andrew England; Richard Mc Williams
Journal:  Ulster Med J       Date:  2013-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.